RBC Capital analyst Trung Huynh reiterated an Outperform rating and $260.00 price target on Abbvie (NYSE: ABBV).The analyst commented: "In-line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE